Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Lipoprotein(a): A Risk Factor and Biomarker in Heart Failure
Author(s): Anna Kowalczys , Joanna Marlęga-Linert , Marcin Gruchała , et al Added: 2 weeks ago

Imaging & Diagnostics

Prevention & Chronic Conditions
Natriuretic Peptides in Heart Failure
Author(s): Olli Arjamaa Added: 1 month ago

Heart Failure
Recovery of Anthracycline-Induced Cardiomyopathy
Author(s): Joe Carver, Osnat Itzhaki Ben Zadok, Jose Álvarez-Cardona Start date: Nov 06, 2025
Join Dr Joe Carver (University of Pennsylvania, US), Dr Osnat Itzhaki Ben Zadok (Rabin Medical Center, IL) and Dr Jose Álvarez Cardona (New York University School of Medicine, US) for this month's Journal Club where they will discuss pathways to cardiac recovery after anthracycline-induced cardiomyopathy.The partnership combines Radcliffe’s rapidly growing global community and expertise in… View more

CV Disease in Special Populations

Heart Failure
Obesity, Cardiac MRI Structure and Non-ischaemic Cardiomyopathy
Author(s): Long Peng , Tao Zeng , Enxi Quan , et al Added: 1 year ago

Cardiovascular Kidney Metabolic

Heart Failure
Metabolic Factors Now Key Drivers of Heart Failure
Added: 4 months ago Source:  Radcliffe Cardiology
The primary drivers of heart failure (HF) have shifted significantly over the past 35 years, with metabolic conditions such as obesity and diabetes now playing a more prominent role than traditional risk factors like myocardial infarction (MI).¹˒² This finding comes from a large US-based study analysing national health trends.MethodologyResearchers conducted a retrospective analysis of data from… View more

MI/ACS

Prevention & Chronic Conditions
David Wheeler
Research Area(s) / Expertise:

Chronic Kidney Disease

 Job title: Professor of Kidney Medicine
David Wheeler is Professor of Kidney Medicine at University College London and Honorary Consultant Nephrologist at the Royal Free London NHS Foundation Trust.Prof Wheeler is a clinician scientist interested in the complications of chronic kidney disease (CKD), specifically those that increase the burden of cardiovascular disease and/or accelerate progression of kidney failure. He has participated… View more
Social Factors Impact Outcomes in HCM Patients
Added: 3 months ago Source:  Radcliffe Cardiology
While social determinants of health (SDOH) are known to influence outcomes in acquired cardiovascular diseases, their impact on conditions with a strong genetic basis, such as hypertrophic cardiomyopathy (HCM), has been less clear.² A new study using data from the Sarcomeric Human Cardiomyopathy Registry (SHaRe) suggests that area-based social factors are independently associated with adverse… View more

Prevention & Chronic Conditions

Electrophysiology & Arrhythmia
Radcliffe Group Celebrates Strong Growth in Impact Factors Across Its Open Access Journals
Added: 10 months ago Source:  Radcliffe Cardiology
23 Jun 2025 – Buckinghamshire, UKRadcliffe Group is delighted to report strong Impact Factor growth across its journals in the latest Journal Citation Reports™ (2024) from Clarivate™. This progress highlights the strength and influence of Radcliffe’s cardiovascular portfolio, made possible by the dedicated efforts of its editorial teams, authors, and reviewers.Cardiac Failure Review (CFR), under… View more
RDW Prognostic Marker in HF and Predictor for Iron Replacement Responsivene
Author(s): Artemio García-Escobar , Rosa Lázaro-García , Javier Goicolea-Ruigómez , et al Added: 1 year ago

Heart Failure
MicroRNAs for Cardiac Regeneration
Author(s): Camilla Olianti , Mauro Giacca Added: 7 months ago

Prevention & Chronic Conditions

Heart Failure